|1.||Grompe, Markus: 8 articles (07/2014 - 04/2003)|
|2.||Tanguay, Robert M: 7 articles (01/2015 - 12/2003)|
|3.||Finegold, Milton: 5 articles (09/2010 - 04/2003)|
|4.||Wang, Xin: 4 articles (03/2015 - 04/2003)|
|5.||Finegold, Milton J: 4 articles (07/2014 - 03/2008)|
|6.||Willenbring, Holger: 4 articles (07/2014 - 04/2003)|
|7.||Tanguay, R M: 4 articles (08/2001 - 12/2000)|
|8.||Nyberg, Scott L: 3 articles (04/2015 - 10/2011)|
|9.||Hickey, Raymond D: 3 articles (04/2015 - 10/2011)|
|10.||Bergeron, Anne: 3 articles (01/2015 - 11/2004)|
07/01/2014 - "To address this uncertainty, we determined whether PG ESC derivatives are effective in rescuing mice with lethal liver failure due to deficiency of fumarylacetoacetate hydrolase (Fah). "
04/01/2015 - "Next, NIS-transduced HCs were transplanted into congenic fumarylacetoacetate hydrolase knockout mice, and this resulted in the prevention of liver failure. "
01/01/2015 - "Using fumarylacetoacetate hydrolase-deficient (Fah(-/-)) mice as a liver-failure model, we confirmed that BMDHs were generated by fusion of BM-derived CD11b(+)F4/80(+)myelomonocytes with resident Fah(-/-) hepatocytes. "
03/01/2015 - "Mice deficient in tyrosine catabolic enzyme fumarylacetoacetate hydrolase (fah(-/-) ) was a useful animal model for studying liver failure. "
10/01/2011 - "Hereditary tyrosinemia type I (HT1) results in hepatic failure, cirrhosis, and hepatocellular carcinoma (HCC) early in childhood and is caused by a deficiency in the enzyme fumarylacetoacetate hydrolase (FAH). "
01/01/1986 - "Recently, studies on hereditary tyrosinemias (Type I) have indicated that the primary enzyme defect in these diseases is a deficiency of liver and renal fumarylacetoacetase. "
01/01/2015 - "Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1."
01/01/2015 - "Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disease caused by a defect of fumarylacetoacetate hydrolase. "
12/01/2013 - "Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive inborn error of metabolism caused by deficiency of fumarylacetoacetate hydrolase enzyme. "
07/01/2013 - "Tyrosinemia type-I results from lack of fumarylacetoacetate hydrolase (FAH), which is a liver enzyme and also shown to be present in lymphocytes, fibroblasts, and cultured amniotic fluid cells. "
|3.||Hepatolenticular Degeneration (Wilson's Disease)
|4.||Liver Diseases (Liver Disease)
07/01/2014 - "Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease."
09/01/2012 - "Loss of the remaining Hgd allele protects from fumarylacetoacetate hydrolase (Fah) deficiency, a genetic liver disease model. "
07/01/2004 - "Liver repopulation with bone marrow-derived hepatocytes (BMHs) can cure the genetic liver disease fumarylacetoacetate hydrolase (Fah) deficiency. "
04/24/2003 - "For example, bone-marrow-derived hepatocytes can repopulate the liver of mice with fumarylacetoacetate hydrolase deficiency and correct their liver disease. "
03/01/1996 - "We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. "
|5.||Metabolic Diseases (Metabolic Disease)
08/01/1995 - "Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). "
10/01/2015 - "Hereditary Tyrosinemia type I (HTI) is a metabolic disease caused by deficiency of fumarylacetoacetate hydrolase enzyme. "
01/01/1998 - "Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a deficient activity of the enzyme fumarylacetoacetase (FAH). "
08/15/2001 - "Patients suffering from the metabolic disease hereditary tyrosinemia type I (HT1), caused by fumarylacetoacetate hydrolase deficiency, have a high risk of developing liver cancer. "
01/16/2001 - "Hereditary tyrosinemia type 1 (HT1) is a severe autosomal recessive metabolic disease associated with point mutations in the human fumarylacetoacetate hydrolase (FAH) gene that disrupt tyrosine catabolism. "
|1.||Tyrosinemia type 1
|6.||Complementary DNA (cDNA)
|7.||Nonsense Codon (Nonsense Mutation)
|8.||Messenger RNA (mRNA)
|9.||Proteins (Proteins, Gene)
|2.||Transplantation (Transplant Recipients)